In a unanimous ruling on June 1, the Supreme Court revived whistleblower lawsuits against pharmacy operators SuperValu and Safeway for allegedly overcharging the government by filing false Medicare and Medicaid reimbursement claims for prescription drugs they sold.
The case concerns the federal False Claims Act (FCA), which is a key tool for the government to crack down on health care fraud.
